Can Wegovy Make You Feel Weak or Fatigued?

What clinical trials actually recorded about fatigue

The STEP 1 trial, published in the New England Journal of Medicine, followed nearly 2,000 adults over 68 weeks using semaglutide 2.4mg. Alongside the well-known gastrointestinal effects, fatigue appeared in the reported side-effect profile across the STEP programme. The NHS semaglutide medicines page lists tiredness explicitly among the common effects people may notice, placing it alongside nausea, headache and dizziness. These effects are not anomalies; they reflect how the body responds to a medicine that meaningfully alters appetite signalling, gastric emptying speed and energy intake all at once. The feeling of weakness is rarely dramatic in the trial data (it tends to present as a low-grade heaviness or reduced stamina rather than an inability to function) but it is real, and worth preparing for. If you want a fuller picture of how semaglutide affects day-to-day wellbeing, the broader guide to how Wegovy makes you feel covers the range of physical and mood-related changes people report.

Why weakness happens, the biology behind it

Wegovy works as a GLP-1 receptor agonist, mimicking a gut hormone that signals fullness and slows the rate at which food leaves the stomach. That mechanism is exactly why it helps with weight management, and exactly why some tiredness is predictable. When appetite drops sharply, total calorie intake often falls faster than people anticipate. If protein intake falls alongside overall calories, the body has less substrate to support muscle function, which can register as weakness rather than simple hunger. Separately, nausea and reduced fluid intake during GI side effects can tip some people toward mild dehydration, which compounds fatigue. There is also a direct neurological component: GLP-1 receptors exist in the brain as well as the gut, and early central effects as the body adapts may contribute to the tiredness some people feel. Understanding how Wegovy influences fullness signals can help explain why eating enough of the right foods takes deliberate effort early on. Some people also notice temperature sensitivity during this adjustment period, the link between semaglutide and feeling cold is a related question worth reading if that applies to you.

When to take weakness seriously, and when not to worry

Mild fatigue in the first week or two after starting or increasing a dose is expected and usually resolves. The MHRA's Yellow Card scheme asks patients to report side effects that concern them, and the MHRA's January 2026 Drug Safety Update specifically highlighted acute pancreatitis as a serious but infrequent risk: severe stomach pain reaching through to the back, with or without vomiting, is a reason to stop the medicine and seek urgent medical help rather than waiting to see whether the weakness passes. Beyond pancreatitis, signs that weakness needs same-day review include extreme dizziness on standing, very dark urine suggesting dehydration, or weakness that is worsening rather than improving day by day. For everyday mild tiredness, practical steps help: keeping the pen in the fridge door as a reminder to take your weekly dose consistently, eating protein at each meal even when appetite is low, and staying well hydrated tend to make the adjustment more manageable. The distinction between ordinary fatigue and a symptom that needs attention is something our prescribers are available to help with. Explore the full Wegovy overview for more context on what the treatment journey typically involves, or read about whether Wegovy causes genuine physical weakness as a separate, deeper question.

How this fits into the overall decision about starting treatment

Fatigue on its own is rarely a reason to stop Wegovy, but it is a reason to make sure the decision to start was made with full information. Wegovy is a prescription-only medicine, and NHS guidance is clear that it is intended for use alongside dietary change and increased activity within appropriate clinical oversight. The semaglutide treatment page outlines who the medicine is licensed for and what that clinical assessment involves. For those thinking about cost alongside everything else, the Wegovy cost guide explains what private treatment typically includes. If you have read this and want to discuss whether Wegovy is right for you (side-effect profile included) start a free consultation and a GPhC-registered prescriber, not an algorithm, will review your answers the same day.